# Trial 2: Research Methodology Validation Report

> **Date**: 2026-02-07
> **Validator**: research-pi (PI)
> **Scope**: Research methodology framework for clau-doom project
> **Documents Reviewed**: 15 (4 foundation, 5 experiment orders, 3 rules, 2 meta, 1 execution plan)

---

## Executive Summary

The clau-doom research methodology framework is **well-designed and scientifically coherent**. The hypothesis system (H-001 through H-008) is testable and properly linked to experiments. The DOE phase transition criteria are clearly defined. The audit trail chain (R102) is correctly established and ready to receive execution results. Decision gates are well-specified with explicit STOP/PROCEED criteria.

However, several issues were identified across eight validation dimensions. The most notable are: (1) the DOE-003 decision gate has an unspecified "gray zone" for marginal results (0.05 < p < 0.10), (2) there is a structural tension between DOE-002 and DOE-005 regarding H-008 with unclear rules for when DOE-005 supersedes or complements DOE-002, (3) the Phase 0-to-1 transition criteria in HYPOTHESIS_BACKLOG.md are inconsistent with the actual experimental plan, and (4) two R102-required documents (SPC_STATUS.md, FMEA_REGISTRY.md) are missing from the repository.

**Overall Verdict**: **ADEQUATE** -- the methodology is scientifically sound and ready for execution after addressing the issues below. No CRITICAL issues found.

**Issue Count**: 0 CRITICAL, 3 MAJOR, 7 MINOR, 5 NOTE

---

## 1. Hypothesis System Evaluation

### 1.1 Overall Assessment

All 8 hypotheses are well-formed, testable, and include formal null/alternative specifications. Each hypothesis includes a rationale, priority, linked experiment, and source reference. The hypothesis backlog follows R102 format requirements.

### 1.2 Per-Hypothesis Evaluation

#### H-001: RAG Agent Outperforms Random Baseline

| Criterion | Assessment |
|-----------|-----------|
| Testable | YES -- clear comparison with statistical test |
| Formal statement | YES -- mu_FULL vs mu_RAND with one-sided alternative |
| Linked to experiment | YES -- DOE-001 |
| Sample size justified | YES -- n=70, power=0.80 for d=0.50 |
| Expected effect stated | YES -- Cohen's d > 1.0 (large) |

**Verdict**: Well-formed. No issues.

#### H-002: RAG Agent Outperforms Rule-Only Baseline

| Criterion | Assessment |
|-----------|-----------|
| Testable | YES |
| Formal statement | YES -- two-sided test (appropriate since direction uncertain) |
| Linked to experiment | YES -- DOE-001 |
| Sample size justified | YES -- n=70, power=0.80 for d=0.50 |
| Expected effect stated | YES -- medium (d >= 0.50) |

**Verdict**: Well-formed. **NOTE** [N-001]: The hypothesis uses a two-sided test while H-001 is implicitly one-sided. This asymmetry is scientifically appropriate (we are less certain RAG beats Rule-Only than RAG beats Random), but should be explicitly documented in the experiment order.

#### H-003: Document Quality Affects Performance

| Criterion | Assessment |
|-----------|-----------|
| Testable | YES -- 3 levels with monotonic prediction |
| Formal statement | YES -- one-way ANOVA |
| Linked to experiment | QUEUED (no DOE assigned yet) -- but DOE-004 covers it |
| Dose-response prediction | YES -- mu_H > mu_D > mu_R |

**Issue** [MINOR, M-001]: The HYPOTHESIS_BACKLOG.md entry says "Linked Experiment: To be assigned (Ablation 1 -- S2-02)" but EXPERIMENT_ORDER_004.md exists and explicitly tests H-003. The backlog entry should be updated to reflect DOE-004 linkage.

#### H-004: Scoring Weights Affect Performance

| Criterion | Assessment |
|-----------|-----------|
| Testable | YES |
| Formal statement | YES -- one-way ANOVA with 4 conditions (primary) |
| Linked to experiment | QUEUED -- no experiment order written |
| Extended design | YES -- 8-condition version for regression on weight simplex |

**Verdict**: Well-formed. Correctly queued pending H-003 results. No issues.

#### H-005: Each Decision Layer Adds Value

| Criterion | Assessment |
|-----------|-----------|
| Testable | YES -- 2^3 factorial with 8 conditions |
| Formal statement | YES -- but stated as 4-condition comparison, design is 8-condition |
| Decision gate | YES -- STOP if Full Stack ~ L0 Only |
| Linked to experiment | DOE-003 (matches) |

**Issue** [MINOR, M-002]: The formal statement in HYPOTHESIS_BACKLOG.md describes 4 conditions (mu_FULL, mu_L01, mu_L0, mu_L2), but DOE-003 actually implements all 8 conditions of the 2^3 factorial. The formal statement should be expanded to match the actual 8-condition design, or a note should clarify that the primary comparison is among 4 key conditions while the full 2^3 enables interaction estimation.

#### H-006: Memory Parameter Affects Kill Efficiency

| Criterion | Assessment |
|-----------|-----------|
| Testable | YES |
| Formal statement | YES -- two-level comparison |
| Linked to experiment | YES -- DOE-002 |
| Correctly combined | YES -- originally OFAT, combined into 2^2 factorial |

**Verdict**: Well-formed. The level change documentation (from 3 levels to 2 with center points) is clear.

#### H-007: Strength Parameter Affects Damage Output

| Criterion | Assessment |
|-----------|-----------|
| Testable | YES |
| Formal statement | YES |
| Linked to experiment | YES -- DOE-002 |

**Issue** [MINOR, M-003]: H-007's statement says "higher strength leads to higher kill efficiency" but the title says "Affects Damage Output." The primary response in DOE-002 is kill_rate, not damage_dealt. The title should be aligned with the actual primary response variable being tested.

#### H-008: Memory and Strength Interact

| Criterion | Assessment |
|-----------|-----------|
| Testable | YES |
| Formal statement | YES -- interaction term in 2-factor ANOVA |
| Linked to experiment | YES -- DOE-002 (exploratory) and DOE-005 (confirmatory) |
| Priority elevation | YES -- documented (LOW -> MEDIUM) |

**Issue** [MAJOR, MJ-001]: H-008 is tested in two experiments (DOE-002 and DOE-005) with different designs:
- DOE-002: 2x2 factorial (Memory: 0.3, 0.7; Strength: 0.3, 0.7), 120 factorial episodes, labeled "exploratory"
- DOE-005: 3x2 factorial (Memory: 0.3, 0.5, 0.7; Strength: 0.3, 0.7), 180 factorial episodes + 90 center points, labeled "confirmatory"

The relationship between these two tests of H-008 is ambiguous:
1. If DOE-002 finds a significant interaction, does DOE-005 still run? It appears so (DOE-005 is contingent on DOE-003, not DOE-002).
2. If DOE-002 finds NO interaction but DOE-005 does (with more levels), which result takes precedence?
3. Is DOE-005 a replication, an extension, or a replacement of DOE-002's H-008 test?

**Recommendation**: Document the relationship explicitly. Suggested framing: DOE-002 is a screening test for H-008 (exploratory); DOE-005 is the definitive test (confirmatory). If DOE-002 finds interaction, DOE-005 confirms with finer resolution. If DOE-002 finds no interaction, DOE-005 provides a more sensitive test with additional Memory levels.

### 1.3 Hypothesis System Summary

| Hypothesis | Well-formed | Testable | Linked | Issues |
|-----------|-------------|----------|--------|--------|
| H-001 | YES | YES | DOE-001 | None |
| H-002 | YES | YES | DOE-001 | N-001 (sidedness) |
| H-003 | YES | YES | DOE-004 | M-001 (stale link) |
| H-004 | YES | YES | Queued | None |
| H-005 | YES | YES | DOE-003 | M-002 (formal vs actual) |
| H-006 | YES | YES | DOE-002 | None |
| H-007 | YES | YES | DOE-002 | M-003 (title mismatch) |
| H-008 | YES | YES | DOE-002, DOE-005 | MJ-001 (dual experiment) |

---

## 2. DOE Phase Transition Criteria

### 2.1 Phase 0 -> Phase 1

**Criteria in HYPOTHESIS_BACKLOG.md**:
> "Trigger: >= 3 factors with significant main effects (p < 0.05). Evidence: H-006, H-007, and at least one more factor from OFAT screening."

**Issue** [MAJOR, MJ-002]: This criterion is inconsistent with the actual experimental plan:
1. H-006 and H-007 are tested in a 2^2 factorial (DOE-002), not in OFAT screening.
2. The criterion says "at least one more factor from OFAT screening," but no OFAT experiments are currently planned beyond DOE-001 (which tests agent_type, not a tunable parameter).
3. The plan already skips pure Phase 0 OFAT in favor of combined Phase 0/1 factorial designs.

The actual research plan is: Phase 0 = DOE-001 (baselines) + DOE-002 (factorial) + DOE-003 (ablation). If these succeed, proceed to DOE-004/005. The Phase 0->1 transition criterion as written requires OFAT screening that does not exist in the plan.

**Recommendation**: Revise the Phase 0->1 transition criteria to reflect the actual plan:
- Phase 0 is complete when: (a) Baseline validated (H-001/H-002 via DOE-001), (b) Architecture validated (H-005 via DOE-003), (c) At least 2 agent parameters show significant main effects (H-006/H-007 via DOE-002).
- Phase 1 begins when interaction effects are investigated (H-008 via DOE-005).

### 2.2 Phase 1 -> Phase 2

**Criteria**: "Trigger: Significant interaction effects confirmed in factorial design."

**Assessment**: Clear and measurable. DOE-002 provides an exploratory interaction test, and DOE-005 provides a confirmatory test with curvature detection via center points. If either confirms interaction AND curvature is detected, Phase 2 RSM-CCD is triggered.

**Verdict**: ADEQUATE.

### 2.3 Phase 2 -> Phase 3

**Criteria**: "Trigger: Optimal region identified via RSM, need robustness validation."

**Assessment**: Appropriately vague at this stage. The RSM design is not yet specified (awaiting Phase 1 results). The DOE_CATALOG.md provides sufficient detail on CCD/BBD design options.

**Verdict**: ADEQUATE.

### 2.4 Phase Transition Summary

| Transition | Clear | Measurable | Achievable | Issues |
|-----------|-------|-----------|------------|--------|
| Phase 0->1 | NO | PARTIAL | UNCLEAR | MJ-002 (OFAT mismatch) |
| Phase 1->2 | YES | YES | YES | None |
| Phase 2->3 | YES | YES | TBD | None |

---

## 3. Audit Trail Completeness (R102)

### 3.1 Chain Verification

The R102 audit chain requires: HYPOTHESIS -> EXPERIMENT_ORDER -> EXPERIMENT_REPORT -> FINDINGS.

| Hypothesis | HYPOTHESIS_BACKLOG | EXPERIMENT_ORDER | EXPERIMENT_REPORT | FINDINGS |
|-----------|-------------------|-----------------|-------------------|----------|
| H-001 | Present | DOE-001 | Pending (correct) | Pending (correct) |
| H-002 | Present | DOE-001 | Pending | Pending |
| H-003 | Present | DOE-004 | Pending | Pending |
| H-004 | Present | Not yet assigned | N/A | N/A |
| H-005 | Present | DOE-003 | Pending | Pending |
| H-006 | Present | DOE-002 | Pending | Pending |
| H-007 | Present | DOE-002 | Pending | Pending |
| H-008 | Present | DOE-002, DOE-005 | Pending | Pending |

**Verdict**: All chains are intact for hypotheses with assigned experiments. H-004 is correctly queued without an order.

### 3.2 Cross-Reference Integrity

Each EXPERIMENT_ORDER document contains:
- Hypothesis linkage section referencing HYPOTHESIS_BACKLOG.md
- Audit trail table showing document chain status
- Reference to source design documents (S2-01, S2-02)

**Verified**: All 5 experiment orders contain proper cross-references.

### 3.3 Missing R102 Documents

**Issue** [MINOR, M-004]: R102 specifies 8 required documents. Two are missing from the repository:
- `SPC_STATUS.md` -- not created yet
- `FMEA_REGISTRY.md` -- not created yet

These are listed as authored by research-analyst and research-evolution-mgr respectively. Since no experiments have been executed, their absence is expected but they should be created with template structure before execution begins.

### 3.4 RESEARCH_LOG.md Completeness

The research log contains 2 entries, both dated 2026-02-07. The entries document the design phase completion and the first two experiment orders. However:

**Issue** [MINOR, M-005]: The second research log entry references DOE-001 and DOE-002 but not DOE-003, DOE-004, or DOE-005. Entries for the design of these three experiment orders are missing from the log.

### 3.5 FINDINGS.md Readiness

FINDINGS.md is correctly empty with a well-structured template including all required fields (hypothesis_id, experiment_order_id, experiment_report_id, trust_level, statistical_markers). The template matches R102 requirements.

**Verdict**: Template is R102-compliant and ready for findings.

---

## 4. Decision Gate Analysis

### 4.1 DOE-003 Decision Gate

DOE-003 contains the most critical decision gate in the research plan. It determines whether the RAG architecture is justified.

**STOP Condition** (from DOE-003):
- Full Stack vs L0 Only: p > 0.10, Cohen's d < 0.3
- Action: STOP DOE-004 and DOE-005, investigate architecture

**PROCEED Condition**:
- Full Stack vs L0 Only: p < 0.05, Cohen's d > 0.5
- Action: Proceed to DOE-004, DOE-005

**Issue** [MAJOR, MJ-003]: The decision gate has an unspecified "gray zone" where 0.05 < p < 0.10 or 0.3 < d < 0.5. Specifically:

1. **Case: p = 0.07, d = 0.4** -- Does not meet PROCEED (p < 0.05) or STOP (p > 0.10). What happens?
2. **Case: p = 0.03 but d = 0.35** -- Meets PROCEED on p-value but not effect size. Proceed or not?
3. **Case: p = 0.08, d = 0.6** -- Moderate p-value but large effect size. Suggests underpowered but real effect.

The current gate uses two independent criteria (p-value AND effect size) with different thresholds for STOP vs PROCEED, but does not specify behavior in the gap.

**Recommendation**: Add a CONDITIONAL zone:

```
STOP:       p > 0.10 AND d < 0.3
PROCEED:    p < 0.05 AND d > 0.5
CONDITIONAL: All other cases
  -> If p < 0.10 and d > 0.3: Proceed cautiously to DOE-004 only (not DOE-005)
  -> If p < 0.05 and d < 0.5: Proceed but note effect is small
  -> If p > 0.10 and d > 0.3: Extend sample to n=50 per condition
```

### 4.2 DOE-002 Phase Transition Gate

DOE-002 specifies phase transition criteria for Phase 2 RSM:
- At least one factor significant (p < 0.05, medium+ effect)
- Interaction present (p < 0.10, suggestive)
- OR curvature test significant (p < 0.05)

**Assessment**: These criteria are clear and use appropriate thresholds. The OR condition on curvature is well-justified -- even without interaction, curvature alone warrants RSM investigation.

**Verdict**: ADEQUATE.

### 4.3 DOE-005 Phase Transition Gate

DOE-005 specifies:
- Interaction significant (p < 0.05, eta-squared > 0.06) AND curvature detected (p < 0.05)

**Issue** [NOTE, N-002]: This requires BOTH conditions for Phase 2, while DOE-002 accepts either interaction OR curvature. The inconsistency may be intentional (DOE-005 is a more definitive test) but should be explicitly documented.

### 4.4 Decision Gate Summary

| Gate | Location | Well-defined | Gray zone handled | Severity |
|------|---------|-------------|------------------|----------|
| DOE-003 STOP/PROCEED | DOE-003 | PARTIAL | NO | MJ-003 |
| DOE-002 Phase 2 | DOE-002 | YES | N/A (OR logic) | None |
| DOE-005 Phase 2 | DOE-005 | YES | N/A (AND logic) | N-002 |

---

## 5. PI Boundary Compliance (R101)

### 5.1 Experiment Order Authorship

All 5 experiment orders correctly list "research-pi" as author and include "Execution Instructions for research-doe-runner" sections that delegate implementation. No experiment order contains direct execution commands (Docker, DuckDB, or OpenSearch operations) in the PI's scope.

**Verdict**: Full R101 compliance.

### 5.2 Role Separation in Documents

| Document | Expected Author | Actual Author | Compliance |
|----------|----------------|---------------|-----------|
| HYPOTHESIS_BACKLOG.md | research-pi | research-pi | PASS |
| EXPERIMENT_ORDER_001-005.md | research-pi | research-pi | PASS |
| RESEARCH_LOG.md | research-pi | research-pi | PASS |
| DOE_CATALOG.md | research-pi | research-pi | PASS |
| FINDINGS.md | research-pi | research-pi | PASS |

### 5.3 Delegation Clarity

Each experiment order contains explicit execution instructions for research-doe-runner including:
- Agent MD configuration templates
- DuckDB recording schemas
- Container restart instructions
- Seed set application rules

Each experiment order also specifies analysis handoff to research-analyst with:
- ANOVA model specification
- Residual diagnostic requirements
- Post-hoc comparison methods
- Output document (EXPERIMENT_REPORT_XXX.md)

**Verdict**: Delegation is clear and complete. The PI designs; the executor runs; the analyst analyzes; the PI interprets. R101 fully satisfied.

### 5.4 Boundary Violation Risk

**Issue** [NOTE, N-003]: DOE-005 includes an "Evolution Hook" section where the PI specifies the exact Generation 2 genome (Memory=0.8, Strength=0.8) and the mutation strategy (+0.1 perturbation). This borders on R101 territory -- the PI is making evolution strategy decisions, which is listed as a PI responsibility. However, the specificity of "Memory=0.8, Strength=0.8" reads more like an execution instruction than a strategic decision.

**Recommendation**: Frame the evolution hook as a strategic recommendation with flexibility for research-evolution-mgr: "Apply local perturbation of +/-0.1 around best performer. Primary candidate: perturb both parameters upward."

---

## 6. Experiment Dependencies

### 6.1 Dependency Graph

```
DOE-001 (Baselines) --------> [Independent, no prerequisites]
DOE-002 (Factorial) ---------> [Independent, no prerequisites]
DOE-003 (Layer Ablation) ---> [Independent, no prerequisites]
                               |
                         DECISION GATE
                               |
                     +---------+---------+
                     |                   |
              DOE-004 (Doc Quality)  DOE-005 (Extended Factorial)
              [Depends: DOE-003]     [Depends: DOE-003, DOE-002 results]
```

### 6.2 Explicit Dependencies

| Experiment | Prerequisites | Explicitly Stated | Correctly Ordered |
|-----------|--------------|-------------------|-------------------|
| DOE-001 | None | YES | YES |
| DOE-002 | None | YES | YES |
| DOE-003 | None | YES | YES |
| DOE-004 | DOE-003 GATE pass | YES (in dependency chain) | YES |
| DOE-005 | DOE-003 GATE pass + DOE-002 results | PARTIAL | MOSTLY |

**Issue** [MINOR, M-006]: DOE-005 lists its dependencies as "DOE-003 must complete and validate Full Stack first" and "DOE-004 should complete to ensure RAG is working." However, DOE-004 is listed as "should" not "must." If DOE-004 reveals that document quality does NOT matter, this could invalidate the assumptions underlying DOE-005's full-stack agent configuration (L0+L1+L2 all enabled). The dependency strength should be clarified.

### 6.3 Parallel Execution Opportunities

Wave 1 (parallel): DOE-001, DOE-002, DOE-003 -- correctly identified. All three are independent.

Wave 2 (sequential after gate): DOE-004 then DOE-005.

**Issue** [NOTE, N-004]: DOE-004 and DOE-005 could potentially run in parallel after the gate, since DOE-005 does not strictly depend on DOE-004's results (DOE-005 tests Memory x Strength interaction, not document quality). However, the current plan sequences them. This is conservative and acceptable, but parallel execution would save time.

---

## 7. Reproducibility Framework

### 7.1 Seed Fixation

All 5 experiments specify fixed seed sets with explicit generation formulas:

| Experiment | Formula | Seeds | Unique | Collision |
|-----------|---------|-------|--------|-----------|
| DOE-001 | 42 + i*31 | 70 | YES | 1 with DOE-002 (seed 1592) |
| DOE-002 | 1337 + i*17 | 30 | YES | 1 with DOE-001 |
| DOE-003 | 2023 + i*23 | 30 | YES | None |
| DOE-004 | 7890 + i*13 | 50 | YES | None |
| DOE-005 | 9999 + i*19 | 30 | YES | None |

**Verdict**: Seed fixation is robust. The single cross-experiment collision has negligible impact.

### 7.2 Replication Sufficiency

Can another researcher replicate the entire study from documents alone?

| Component | Documented | Sufficient for Replication |
|----------|-----------|--------------------------|
| Hypothesis statements | YES | YES |
| Factor definitions and levels | YES | YES |
| Design matrices | YES | YES |
| Seed sets (complete lists) | YES | YES |
| Randomized run orders | YES | YES |
| Statistical analysis plans | YES | YES |
| Agent configuration templates | YES | YES |
| DuckDB schemas | YES | YES |
| VizDoom scenario config | YES | YES |
| Expected outcomes | YES | Helpful (not required) |

**Issue** [MINOR, M-007]: The agent MD file templates referenced in experiment orders (DOOM_PLAYER_BASELINE_RANDOM.MD, DOOM_PLAYER_BASELINE_RULEONLY.MD, DOOM_PLAYER_GEN1.MD, DOOM_PLAYER_DOE002.MD) do not exist in the repository yet. While the experiment orders describe what these files should contain, the actual template files must be created before execution. An external replicator would need to construct these from the descriptions.

### 7.3 Software Version Pinning

**Issue** [NOTE, N-005]: No experiment order specifies exact software versions (VizDoom version, Python version, Rust toolchain version, OpenSearch version). While CLAUDE.md specifies version ranges (Python 3.11+, Go 1.21+, OpenSearch 2.x), exact version pinning is important for long-term reproducibility.

### 7.4 Reproducibility Verdict

The documentation is sufficient for replication by someone familiar with the clau-doom system. For external replication, agent MD templates and exact version specifications would be needed.

---

## 8. Phase Progression Logic

### 8.1 Phase 0: Baseline + Ablation Foundation

**Purpose**: Establish that the system works (baselines) and that each component matters (ablation).

**Assessment**: This is the correct starting point. Before optimizing parameters, you must validate that the architecture itself is sound. The three-experiment design (DOE-001 for baselines, DOE-002 for parameter screening, DOE-003 for architecture validation) covers the essential questions:
1. Does the agent beat random/rule-only? (DOE-001)
2. Do agent parameters matter? (DOE-002)
3. Does each architectural layer contribute? (DOE-003)

The decision gate at DOE-003 is critical and correct -- if the multi-layer architecture is not better than rules alone, optimizing parameters within that architecture is premature.

**Verdict**: ADEQUATE. Phase 0 design is scientifically sound.

### 8.2 Phase 0/1 Hybrid

DOE-002 is labeled "Phase 0/1" because it combines main effects screening (Phase 0) with interaction detection (Phase 1). This is a good design decision -- the 2^2 factorial tests interaction at zero additional cost over separate OFAT experiments.

**Assessment**: The hybrid labeling is accurate and well-justified. The efficiency gain (150 episodes vs 360 for separate OFAT + factorial) is significant.

**Verdict**: ADEQUATE.

### 8.3 Phase 1: Interaction Studies

DOE-005 extends DOE-002 with additional Memory levels (3 instead of 2) and center points for curvature detection. The evolution hook adds a practical validation component.

**Assessment**: This is a natural extension. The 3x2 design provides finer resolution on Memory while maintaining the binary Strength comparison. Center points test whether the linear model from DOE-002 is adequate.

**Verdict**: ADEQUATE, with the caveat that the dual-testing of H-008 (DOE-002 + DOE-005) needs clearer framing (see MJ-001).

### 8.4 Phase 2-3 Progression

RSM-CCD and Taguchi/Split-Plot designs are correctly positioned as advanced phases. The DOE_CATALOG.md provides comprehensive descriptions of when and how to use each design type.

**Assessment**: The progression (OFAT/factorial -> RSM -> robust/sequential) follows standard DOE methodology. The design selection guide decision tree is correct and practical.

**Verdict**: ADEQUATE.

### 8.5 Domain Appropriateness

For a VizDoom research domain with stochastic outcomes and multiple agent parameters, the DOE-driven approach is appropriate. The key question is whether 30 episodes per condition provides sufficient power given the inherent variability of game environments.

**Assessment**: The power analyses are correctly performed (n=30 per cell for f=0.25 gives approximately 0.80 power). However, VizDoom variability is unknown until the first experiments run. The adaptive stopping rules in DOE-001 (extend to n=100 if underpowered) provide a reasonable safety net.

**Verdict**: ADEQUATE.

---

## Issues Summary

### CRITICAL (0)

None.

### MAJOR (3)

| ID | Issue | Location | Impact | Recommendation |
|----|-------|----------|--------|---------------|
| MJ-001 | H-008 tested in two experiments (DOE-002 and DOE-005) without clear precedence rules | HYPOTHESIS_BACKLOG.md, DOE-002, DOE-005 | Ambiguous interpretation if results conflict | Document DOE-002 as exploratory screening, DOE-005 as confirmatory test; specify precedence |
| MJ-002 | Phase 0->1 transition criteria reference OFAT screening that does not exist in plan | HYPOTHESIS_BACKLOG.md Phase Transition Criteria | Transition criteria cannot be met as written | Revise to reference actual experiments (DOE-002 main effects + DOE-003 layer validation) |
| MJ-003 | DOE-003 decision gate has unspecified gray zone (0.05 < p < 0.10) | EXPERIMENT_ORDER_003.md | Unclear action for marginal results | Add CONDITIONAL zone with explicit rules for each case |

### MINOR (7)

| ID | Issue | Location | Impact | Recommendation |
|----|-------|----------|--------|---------------|
| M-001 | H-003 backlog entry says "To be assigned" but DOE-004 exists | HYPOTHESIS_BACKLOG.md | Stale cross-reference | Update linked experiment to DOE-004 |
| M-002 | H-005 formal statement describes 4 conditions but DOE-003 implements 8 | HYPOTHESIS_BACKLOG.md | Mismatch between stated and actual design | Add note clarifying the 4 key conditions within the 8-condition factorial |
| M-003 | H-007 title says "Affects Damage Output" but primary response is kill_rate | HYPOTHESIS_BACKLOG.md | Title-content misalignment | Rename to "Strength Parameter Affects Kill Efficiency" |
| M-004 | SPC_STATUS.md and FMEA_REGISTRY.md missing (R102 required) | research/ | Incomplete R102 document set | Create template files before execution |
| M-005 | Research log missing entries for DOE-003, DOE-004, DOE-005 design | RESEARCH_LOG.md | Incomplete audit trail | Add entries documenting the design of these experiments |
| M-006 | DOE-005 dependency on DOE-004 is "should" not "must" | EXPERIMENT_ORDER_005.md | Unclear dependency strength | Clarify whether DOE-004 results affect DOE-005 validity |
| M-007 | Agent MD template files referenced in orders do not exist yet | Various EXPERIMENT_ORDER files | Cannot execute without templates | Create template files before execution |

### NOTE (5)

| ID | Issue | Location | Impact |
|----|-------|----------|--------|
| N-001 | H-001 one-sided vs H-002 two-sided test asymmetry undocumented | EXPERIMENT_ORDER_001.md | Clarity |
| N-002 | DOE-002 uses OR logic for Phase 2 gate, DOE-005 uses AND logic | DOE-002, DOE-005 | Inconsistency in gate stringency |
| N-003 | DOE-005 evolution hook specifies exact genome values (PI boundary edge case) | EXPERIMENT_ORDER_005.md | Minor R101 concern |
| N-004 | DOE-004 and DOE-005 could run in parallel but are sequenced | EXECUTION_PLAN.md | Efficiency opportunity |
| N-005 | No exact software version pinning across experiment orders | All EXPERIMENT_ORDER files | Long-term reproducibility |

---

## Methodology Framework Assessment

### Strengths

1. **Comprehensive hypothesis system**: 8 well-formed, testable hypotheses covering baselines, ablation, parameter screening, and interaction.
2. **Efficient design consolidation**: Combining H-006/H-007/H-008 into DOE-002 saves 210 episodes.
3. **Decision gate architecture**: DOE-003's STOP/PROCEED gate prevents wasted computation on a flawed architecture.
4. **Consistent statistical framework**: Every experiment specifies primary/secondary responses, analysis plan, diagnostics, effect sizes, and power analysis.
5. **Seed fixation**: Complete reproducibility through arithmetic seed sequences with documented formulas.
6. **Clear PI boundary**: All experiment orders delegate execution and analysis to appropriate agents.
7. **Trust level framework**: Four-level system (HIGH/MEDIUM/LOW/UNTRUSTED) with explicit criteria and actions.

### Weaknesses

1. **Phase transition criteria are stale**: Written for a plan that included OFAT screening, but the actual plan uses factorial designs.
2. **Decision gate gray zone**: The most critical gate (DOE-003) lacks handling for marginal results.
3. **Dual H-008 testing**: Without clear precedence rules, conflicting results could create ambiguity.
4. **Missing template files**: Agent MD templates and two R102 documents need to be created.

---

## Final Verdict

### ADEQUATE

The clau-doom research methodology framework is scientifically sound, statistically rigorous, and operationally coherent. The issues identified are all addressable through documentation updates and clarifications -- no fundamental redesign is needed.

**Required before execution** (3 items):
1. Resolve MJ-003: Add gray zone handling to DOE-003 decision gate
2. Resolve M-004: Create SPC_STATUS.md and FMEA_REGISTRY.md templates
3. Resolve M-007: Create agent MD template files referenced in experiment orders

**Recommended before execution** (3 items):
1. Resolve MJ-001: Clarify DOE-002 vs DOE-005 relationship for H-008
2. Resolve MJ-002: Update Phase 0->1 transition criteria to match actual plan
3. Resolve M-001, M-003, M-005: Update stale cross-references in HYPOTHESIS_BACKLOG.md and RESEARCH_LOG.md

---

*Report generated by research-pi. Validation performed against R100 (Experiment Integrity), R101 (PI Boundary), and R102 (Research Audit Trail) rules.*
